Seattle — Seattle, Washington

Seattle is a clinical research site located in Seattle, Washington, United States 98101.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Seattle has participated in 11 clinical trials with 3 currently active.

Therapeutic areas: Clostridium Difficile Infection Recurrence, Open-angle Glaucoma, Ocular Hypertension.

Sponsors: Finch Research and Development LLC., Alcon Research, Rebiotix Inc..

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Seattle?

Seattle has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Seattle conducted?

Seattle has 11 clinical trials on record, with 3 currently active. Their work covers Clostridium Difficile Infection Recurrence, Open-angle Glaucoma, Ocular Hypertension.

Is Seattle accredited by Crixeo Health?

Yes — Seattle holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Seattle?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.